AstraZeneca Doubles Down On Amyloidosis With Neurimmune Alliance

Fuels Ambition To Be Leading Heart Failure Firm

 
• By Kevin Grogan
AstraZeneca
• Source: Shutterstock: Elzbieta Krzysztof

More from Rare Diseases

More from Scrip